Biotech News
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
investor.precisionbiosciences.com2026-05-06 15:09 EST
DURHAM, N.C. --(BUSINESS WIRE)--Apr. 8, 2026-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the Company will participate in